Obexelimab on Rheumatology Digesthttps://rheumatologydigest.org/tags/obexelimab/Recent content in Obexelimab on Rheumatology DigestHugoen-usSat, 03 Oct 2026 05:00:00 +0530Obexelimab in IgG4-Related Disease: INDIGO Trialhttps://rheumatologydigest.org/posts/obexelimab-igg4-rd-indigo/Sat, 03 Oct 2026 05:00:00 +0530https://rheumatologydigest.org/posts/obexelimab-igg4-rd-indigo/Obexelimab roughly halved IgG4-RD flares and cut steroid rescue by two-thirds against placebo — but the comparator was a steroid taper, not an active drug.